Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Neal Carter, President, Okanagan Speciality Fruit

Neal Carter, President of Okanagan Specialty Fruit discusses the development of the Arctic Apple at the 2013 BIO International Convention.

Dr. Trevor Mundel, President Global Health, Gates Foundation

At the 2013 BIO International Convention, Mundel discusses biotech start-ups and how biotech and technology can help meet needs in developing countries. The Global Burden of Disease Study 2010 (GBD 2010) is the largest ever systematic effort to describe the global distribution and causes of a wide array of major diseases, injuries, and health risk factors. The results show that infectious diseases, maternal and child illness, and malnutrition now cause fewer deaths and less illness than they did twenty years ago.

Dr. Richard Mohs, Distinguished Research Fellow, Eli Lilly

Dr. Richard Mohs, Distinguished Research Fellow, Eli Lilly discusses the importance of early diagnosis in Alzheimer's at the 2013 BIO International Convention.

Governor Dennis Daugaard, South Dakota; Governor Jay Nixon, Missouri; Governor Rick Perry, Texas; Governor Tom Corbett, Pennsylvania networking and discussing the future of biotech.

Governor Dennis Daugaard, South Dakota; Governor Jay Nixon, Missouri; Governor Rick Perry, Texas; Governor Tom Corbett, Pennsylvania networking and discussing the future of biotech at the 2013 BIO International Convention.

Governor Jay Nixon, Missouri

Governor Jay Nixon of Missouri announces huge deal at the 2013 BIO International Convention. Monsanto will invest $400 million to increase their research footprint in Missouri, adding 675 new high tech jobs.

Exhibitor Hospitality Receptions: Highlights from Tuesday Evening

Wigs, roses, bourbon, and bikes are just a taste of what was happening at the Exhibitor Hospitality Receptions on Tuesday evening as BIO attendees loosened their ties, kicked off their heels, and hit the BIO Exhibition floor at the 2013 BIO International Convention.

Rachel King, CEO, GlycoMimetics (BIO Chair) with Kate Neville (Women in Bio)

At the 2013 BIO International Convention, Rachel King discusses how we can enhance the climate for innovation with communication, strong and helpful FDA, and need to protect financial incentives so we can deliver the innovations.

International Presence at the 2013 BIO International Convention

A look at the wide range of countries represented at the 2013 BIO International Convention.

Chris Morrison, EBI, interviews Glen Giovannetti, Ernst & Young

Chris Morrison, Editor, Elsevier Business Intelligence, interviews Glen Giovannetti, Global Life Sciences Sector Leader, Ernst & Young about the newly released Beyond Borders Report at the 2013 BIO International Convention.

David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP

Published on Apr 23, 2013 David Kappos, former Director, US Patent and Trade Office and current Partner Cravath, Swaine and Moore, LLP discusses the Canadian Utility Requirement at the 2013 BIO International Convention.